News/ News/ R&D ViGeneron to develop next-gen eye gene therapies after funding round Richard Staines ophthalmology, R&D, ViGeneron 0 Comment Germany’s ViGeneron is to advance development of its next-generation ophthalmology gene therapy pipeline after a series A financing Share X ViGeneron to develop next-gen eye gene therapies after funding round https://pharmaphorum.com/news/vigeneron-to-develop-next-gen-eye-gene-therapies/